$ABEO

$4.45 +$0.14 (3.25%) Live

$ABEO Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 57.2M shares outstanding

Who owns ABEO?

By type of holder

Institutions 68.5% Insiders 6.2% Everyone else 25.3%

Concentration Top 10 holders own 43.4%

Nantahala Capital Management, LLC 9.0% · James Russell Revocable Trust 6.1%

Institutional ownership

68.5%

-0.6 pts vs last qtr

Institutional holders

124

+17 vs last qtr

Net shares bought

−339.8K

by institutions in Q2 2026

New / sold out

31 / 14

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

OneDigital Investment Advisors LLC NEW +1.7M
AWM Investment Company, Inc. +683.0K

Biggest sellers in Q2 2026

Montanova Capital, LLC −2.2M
683 Capital Management, LLC SOLD OUT −770.0K

Who is planning to sell?

Notices of proposed sale, last 12 months

$4.15M

33 notices from 9 people

Shares covered

732.3K

1.28% of the company

Arranged in advance

13%

of the value is under a 10b5-1 plan

Under a 10b5-1 plan No plan

Largest proposed sellers

Seshadri Vishwas Officer $1.52M
Silverstein Christine Berni Former director $847K

Every notice on Red Flags →

A Form 144 is notice of a planned sale, not the sale itself. What insiders actually sold is on Insider Transactions.

Is your stake being diluted?

Diluted share count, FY2023–FY2025

+209.3%

+75.88% a year

Each share's claim on the business

−67.7%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

— vs $22.2M

over 3 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years0% 3–5 years41% 1–3 years28% Under 1 year31%

Quarterly turnover

15.8%

of institutional shares changed hands

Top 10 managers, median time held

1.5 years

Super Investors

Investment managers reporting ABEO on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
NC Nantahala Capital Management, LLC	5.1M	8.98%	+123.4K (+2.5%)	2022	1.1%
Shares held by quarter Peak holding5.1M (Q2'26) Change over 8 quarters+1.7M Share of the company8.980% Nantahala Capital Management, LLC's full portfolio →
B BlackRock, Inc.	3.4M	5.86%	+156.9K (+4.9%)	2022	0.0%
Shares held by quarter Peak holding3.4M (Q2'26) Change over 8 quarters+2.9M Share of the company5.860% BlackRock, Inc.'s full portfolio →

Nantahala Capital Management, LLC

5.1M

% of company

8.98%

Change vs last qtr

+123.4K (+2.5%)

Held since

2022

BlackRock, Inc.

3.4M

% of company

5.86%

Change vs last qtr

+156.9K (+4.9%)

Held since

2022

28 more super investors behind a free account

See every manager holding Abeona Therapeutics Inc, how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting ABEO on Form N-PORT; together they hold 13.0% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
VT Vanguard Total Stock Market Index Fund Vanguard Index Funds	$9.45M	1.5M	2.67%	0.00%	June 30, 2026
IR iShares Russell 2000 ETF iShares Trust	$7.33M	1.2M	2.07%	0.01%	June 30, 2026

Vanguard Total Stock Market Index Fund

Vanguard Index Funds

Position value

$9.45M

% of company

2.67%

% of the fund

0.00%

As of

June 30, 2026

iShares Russell 2000 ETF

iShares Trust

Position value

$7.33M

% of company

2.07%

% of the fund

0.01%

As of

June 30, 2026

23 more funds behind a free account

See every fund holding Abeona Therapeutics Inc and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
JR James Russell Revocable Trust 5%+ holder 13D · 6.1%	3.5M	6.09%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company6.090% Disclosed stake13D · 6.1% View the 13D/G filing →
SV Seshadri Vishwas Insider	1.3M	2.25%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company2.250% Seshadri Vishwas's insider activity →

James Russell Revocable Trust

5%+ holder13D · 6.1%

3.5M

% of company

6.09%

Change vs last qtr

—

Held since

—

Seshadri Vishwas

Insider

1.3M

% of company

2.25%

Change vs last qtr

—

Held since

—

12 more holders behind a free account

See every insider and 5%+ holder of Abeona Therapeutics Inc.

Comments